State Street SPDR S&P U.S. Health Care Select Sect UCITS ETF (SWX:SXLV)

Switzerland · Delayed Price · Currency is CHF · Price in USD

52.28

-0.18 (-0.34%)

Last updated: Sep 21, 2026, 1:30 PM CET

Assets	547.26M
Expense Ratio	n/a
PE Ratio	n/a
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	+24.21%

Volume	3,126
Open	52.39
Previous Close	52.46
Day's Range	52.28 - 52.39
52-Week Low	41.29
52-Week High	54.56
Beta	n/a
Holdings	63
Inception Date	Jul 7, 2015

About SXLV

SSgA SPDR ETFs Europe II Public Limited Company - State Street SPDR S&P U.S. Health Care Select Sect UCITS ETF is an exchange traded fund launched and managed by State Street Global Advisors Limited. It is co-managed by State Street Global Advisors, Inc. The fund invests in the public equity markets of the United States. It seeks to invest in the stocks of companies operating in the health care sector. The fund invests in the stocks of large-cap companies. It seeks to replicate the performance of the S&P Health Care Select Sector Index, by investing in the stocks of companies as per their weightings in the index. SSgA SPDR ETFs Europe II Public Limited Company - State Street SPDR S&P U.S. Health Care Select Sect UCITS ETF was formed on July 7, 2015 and is domiciled in Ireland.

Asset Class Equity

Category Sector Equity Healthcare

Stock Exchange SIX Swiss Exchange

Ticker Symbol SXLV

Performance

SXLV had a total return of 24.21% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.95%.

Top 10 Holdings

60.88% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	15.14%
Johnson & Johnson	JNJ	10.67%
AbbVie Inc.	ABBV	7.65%
Merck & Co., Inc.	MRK	5.94%
UnitedHealth Group Incorporated	UNH	5.55%
Thermo Fisher Scientific Inc.	TMO	3.95%
Amgen Inc.	AMGN	3.42%
Gilead Sciences, Inc.	GILD	3.05%
Abbott Laboratories	ABT	2.91%
Pfizer Inc.	PFE	2.59%

View More Holdings